Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Rats can't grow new hair follicles after skin wounds, unlike mice, due to differences in gene expression and response to WNT signaling.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Keeping β-catenin levels high in mammary cells disrupts their development and branching.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The substance DMC helps get rid of aging cells by triggering a process that causes cell death, which could treat age-related diseases.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

TGF-β2 plays a key role in human hair growth and development.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Chitosan slows root hair growth and causes a buildup of callose at low concentrations, but at high concentrations, it only inhibits growth without callose buildup.

Cactus extract from Notocactus ottonis may help promote hair growth.

A specific genetic deletion in goats affects cashmere yield and thickness.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.